Beyond the numbers, patients often experience increased energy, less joint pain, improved sleep quality, enhanced self-esteem, and reduced risk factors for heart disease, diabetes, and other obesity-related conditions
63-110 Clinicians may select one option first over another based on certain prominent presenting symptoms, for example, preferring low-dose naltrexone when pain is a prominent feature or guanfacine when hyperadrenergic orthostatic intolerance is a prominent feature
Hair changes Telogen effluvium, temporary hair shedding associated with rapid weight loss, has been reported by some tirzepatide users
However, it has been extensively studied, and its safety profile is well-documented
Despite these guidelines, there have been case reports showing that large amounts of gastric contents continue to remain during procedures
Each picture takes 5 minutes